Expression of concern: Compensatory increase of transglutaminase 2 is responsible for resistance to mTOR inhibitor treatment.
Saved in:
| Main Author: | PLOS ONE Editors |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2020-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0227851&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Correction: AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake.
by: PLOS ONE Staff
Published: (2016-01-01) -
Retraction: Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
by: PLOS One Editors
Published: (2025-01-01) -
Correction: Retraction: Tanshinone IIA Inhibits HIF-1α and VEGF Expression in Breast Cancer Cells via mTOR/p70S6K/RPS6/4E-BP1 Signaling Pathway.
by: PLOS One Editors
Published: (2025-01-01) -
Expression of Concern: Revealing the dynamics of saffron growth: Optimizing corm size and planting depth for increased yield synergies.
by: PLOS ONE Editors
Published: (2024-01-01) -
Expression of Concern: General sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC.
by: PLOS One Editors
Published: (2025-01-01)